GIOSTAR USA (HEADQUARTER)

About

Regenerative medicine has been called the “next evolution of medical treatments,” by the U.S. Department of Health and Human Services. “With its potential to heal, this new field of science is expected to revolutionize health care.” Global Institute of Stem Cell Therapy and Research (GIOSTAR), headquartered in San Diego, California (U.S.A.), was formed with the vision to provide stem cell based therapy to aid those suffering from degenerative or genetic diseases around the world. GIOSTAR is one the first organizations in the world to get US FDA approval in April 2020 to treat COVID-19 patients with its proprietary stem cells treatment under FDA Compassionate Use Program: See following two new video coverage by ABC NEWS Channel 10 San Diego

Business Hours